Abstracts submitted to the Annual Meeting are considered confidential from the time of submission. Prior to the information being publicly released in conjunction with the Annual Meeting, the author, coauthors, sponsor of the research, journalists, and others may not
- make the information public, or provide it to others who may make it public (such as news media),
- publish or present the information or provide it to others who may publish or present it,
- use the information for trading in the securities of any issuer, or provide it to others who may use it for securities trading purposes.
For a study to be eligible for acceptance into the Annual Meeting, information contained in the abstract, as well as additional data and information to be presented about the study at the Annual Meeting, must not be disclosed before the findings have been publicly released in conjunction with the Annual Meeting. If information from the abstract or additional study data are disclosed in advance of public release in conjunction with the Annual Meeting, the abstract will no longer be eligible for inclusion in the Annual Meeting, or will be subject to removal from the Annual Meeting, unless an official Confidentiality Policy Exception applies.
Furthermore, the contents and conclusions of the abstract must not be presented at any scientific, medical, or educational meeting of 500 registrants or more or be published in a scientific, medical, or educational publication (in any medium), in whole or in part, before the Annual Meeting. ASCO-cosponsored meetings represent an exception to this restriction on prior presentation and publication. Studies submitted to the Gastrointestinal Cancers Symposium, Genitourinary Cancers Symposium, Breast Cancer Symposium, Annual Meeting on Molecular Markers in Cancer, and other ASCO-cosponsored meetings where ASCO is the lead sponsor are eligible for acceptance even if previously presented or published in the scientific, medical, or educational arena. Abstracts presented at these particular ASCO meetings may also be submitted for presentation at any other ASCO meeting. Authors are encouraged to provide updated data in the abstract, as the novelty of the data will be taken into account during the abstract selection process.